Genovate Biotechnology Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Chia-Chen Chu
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 1.5yrs |
Recent management updates
Recent updates
Reflecting on Genovate Biotechnology's (GTSM:4130) Share Price Returns Over The Last Five Years
Mar 09Does It Make Sense To Buy Genovate Biotechnology Co., Ltd. (GTSM:4130) For Its Yield?
Feb 10Genovate Biotechnology Co., Ltd.'s (GTSM:4130) Dismal Stock Performance Reflects Weak Fundamentals
Jan 04How Much Did Genovate Biotechnology's(GTSM:4130) Shareholders Earn From Share Price Movements Over The Last Five Years?
Dec 08CEO
Chia-Chen Chu
no data
Tenure
Chia-Chen Chu is General Manager & Director of Genovate Biotechnology Co., Ltd.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & CSO | no data | no data | 0.20% NT$ 5.0m | |
General Manager & Director | no data | no data | no data | |
Supervisor | no data | no data | no data | |
Supervisor | 18.3yrs | no data | no data | |
Independent Director | no data | no data | no data | |
Independent Director | 1.5yrs | no data | no data | |
Representative Director | 1.5yrs | no data | no data | |
Independent Director | no data | no data | no data | |
Representative Director | 1.5yrs | no data | no data | |
Independent Director | less than a year | no data | no data |
1.5yrs
Average Tenure
Experienced Board: 4130's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.